Physician profile
Ryu Yoshida
NPI 1720348162
$9,606.56
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,134 · 2020: $1,137 · 2021: $416 · 2022: $97.94 · 2023: $933 · 2024: $2,889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,977 · Travel and Lodging: $844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,977.28 |
| Travel and Lodging | $844.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,729.23 | 2019-2023 | Distal Extremities Implants Soft Tissue H&W Mini Tightropes |
| Trimed, INC. | $2,489.66 | 2024 | |
| Acumed LLC | $1,321.32 | 2019 | |
| Micromed INC | $1,102.90 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $552.82 | 2019-2023 | Xiaflex |
| Skeletal Dynamics INC | $310.60 | 2019 | |
| Axogen | $305.55 | 2019-2022 | |
| Polynovo North America LLC | $275.05 | 2024 | Novosorb Btm |
| Bioventus LLC | $122.29 | 2019 | |
| Sonex Health, INC. | $100.00 | 2024 | Sx-One Microknife |
| Saxum Surgical, INC. | $90.70 | 2023 | |
| Zimmer Biomet Holdings, INC. | $71.39 | 2021 | |
| Checkpoint Surgical, INC | $54.03 | 2020-2022 | |
| Integra Lifesciences Corporation | $37.51 | 2020 | |
| Convatec INC. | $23.85 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $19.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryu Yoshida listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.